Multiparametric magnetic resonance imaging of prostate cancer

In India, prostate cancer has an incidence rate of 3.9 per 100,000 men and is responsible for 9% of cancer-related mortality. It is the only malignancy that is diagnosed with an apparently blind technique, i.e., transrectal sextant biopsy. With increasing numbers of high-Tesla magnetic resonance ima...

Descripción completa

Detalles Bibliográficos
Autores principales: Hedgire, Sandeep S, Oei, Tamara N, Mcdermott, Shaunagh, Cao, Kai, Patel M, Zena, Harisinghani, Mukesh G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Gu Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624737/
https://www.ncbi.nlm.nih.gov/pubmed/23599562
http://dx.doi.org/10.4103/0971-3026.107176
_version_ 1782266051125313536
author Hedgire, Sandeep S
Oei, Tamara N
Mcdermott, Shaunagh
Cao, Kai
Patel M, Zena
Harisinghani, Mukesh G
author_facet Hedgire, Sandeep S
Oei, Tamara N
Mcdermott, Shaunagh
Cao, Kai
Patel M, Zena
Harisinghani, Mukesh G
author_sort Hedgire, Sandeep S
collection PubMed
description In India, prostate cancer has an incidence rate of 3.9 per 100,000 men and is responsible for 9% of cancer-related mortality. It is the only malignancy that is diagnosed with an apparently blind technique, i.e., transrectal sextant biopsy. With increasing numbers of high-Tesla magnetic resonance imaging (MRI) equipment being installed in India, the radiologist needs to be cognizant about endorectal MRI and multiparametric imaging for prostate cancer. In this review article, we aim to highlight the utility of multiparamteric MRI in prostate cancer. It plays a crucial role, mainly in initial staging, restaging, and post-treatment follow-up.
format Online
Article
Text
id pubmed-3624737
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36247372013-04-18 Multiparametric magnetic resonance imaging of prostate cancer Hedgire, Sandeep S Oei, Tamara N Mcdermott, Shaunagh Cao, Kai Patel M, Zena Harisinghani, Mukesh G Indian J Radiol Imaging Gu Imaging In India, prostate cancer has an incidence rate of 3.9 per 100,000 men and is responsible for 9% of cancer-related mortality. It is the only malignancy that is diagnosed with an apparently blind technique, i.e., transrectal sextant biopsy. With increasing numbers of high-Tesla magnetic resonance imaging (MRI) equipment being installed in India, the radiologist needs to be cognizant about endorectal MRI and multiparametric imaging for prostate cancer. In this review article, we aim to highlight the utility of multiparamteric MRI in prostate cancer. It plays a crucial role, mainly in initial staging, restaging, and post-treatment follow-up. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3624737/ /pubmed/23599562 http://dx.doi.org/10.4103/0971-3026.107176 Text en Copyright: © Indian Journal of Radiology and Imaging http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Gu Imaging
Hedgire, Sandeep S
Oei, Tamara N
Mcdermott, Shaunagh
Cao, Kai
Patel M, Zena
Harisinghani, Mukesh G
Multiparametric magnetic resonance imaging of prostate cancer
title Multiparametric magnetic resonance imaging of prostate cancer
title_full Multiparametric magnetic resonance imaging of prostate cancer
title_fullStr Multiparametric magnetic resonance imaging of prostate cancer
title_full_unstemmed Multiparametric magnetic resonance imaging of prostate cancer
title_short Multiparametric magnetic resonance imaging of prostate cancer
title_sort multiparametric magnetic resonance imaging of prostate cancer
topic Gu Imaging
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624737/
https://www.ncbi.nlm.nih.gov/pubmed/23599562
http://dx.doi.org/10.4103/0971-3026.107176
work_keys_str_mv AT hedgiresandeeps multiparametricmagneticresonanceimagingofprostatecancer
AT oeitamaran multiparametricmagneticresonanceimagingofprostatecancer
AT mcdermottshaunagh multiparametricmagneticresonanceimagingofprostatecancer
AT caokai multiparametricmagneticresonanceimagingofprostatecancer
AT patelmzena multiparametricmagneticresonanceimagingofprostatecancer
AT harisinghanimukeshg multiparametricmagneticresonanceimagingofprostatecancer

Ejemplares similares